TW202454B - - Google Patents

Download PDF

Info

Publication number
TW202454B
TW202454B TW081104045A TW81104045A TW202454B TW 202454 B TW202454 B TW 202454B TW 081104045 A TW081104045 A TW 081104045A TW 81104045 A TW81104045 A TW 81104045A TW 202454 B TW202454 B TW 202454B
Authority
TW
Taiwan
Prior art keywords
compound
group
salt
alkyl
carboxy
Prior art date
Application number
TW081104045A
Other languages
English (en)
Chinese (zh)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of TW202454B publication Critical patent/TW202454B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW081104045A 1991-05-28 1992-05-23 TW202454B (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111406A GB9111406D0 (en) 1991-05-28 1991-05-28 New cephem compounds and processes for preparation thereof

Publications (1)

Publication Number Publication Date
TW202454B true TW202454B (en, 2012) 1993-03-21

Family

ID=10695670

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081104045A TW202454B (en, 2012) 1991-05-28 1992-05-23

Country Status (4)

Country Link
JP (1) JPH06510523A (en, 2012)
GB (1) GB9111406D0 (en, 2012)
TW (1) TW202454B (en, 2012)
WO (1) WO1992021683A1 (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI547496B (zh) * 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
AU2005219718A1 (en) * 2004-03-05 2005-09-15 Shionogi & Co., Ltd. 3-pyridinium methylcephem compound
EP2209474A4 (en) 2007-10-09 2013-07-24 Sopharmia Inc BROAD SPECTRUM BETA-LACTAMASE INHIBITORS
ME02666B (me) 2008-10-31 2017-06-20 Shionogi & Co Cefalosporin sa kateholskom grupom
CA2795322A1 (en) 2010-04-05 2011-10-13 Shionogi & Co., Ltd. Cephem compound having catechol group
US8883773B2 (en) 2010-04-05 2014-11-11 Shionogi & Co., Ltd. Cephem compound having pseudo-catechol group
US9085589B2 (en) 2010-04-28 2015-07-21 Shionogi & Co., Ltd. Cephem derivative
KR101719556B1 (ko) * 2011-03-30 2017-03-24 주식회사 레고켐 바이오사이언스 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물
KR20140039202A (ko) 2011-04-28 2014-04-01 시오노기세야쿠 가부시키가이샤 카테콜 또는 의사 카테콜 구조를 갖는 신규 세펨 화합물
WO2013002215A1 (ja) 2011-06-27 2013-01-03 塩野義製薬株式会社 ピリジニウム基を有するセフェム化合物
WO2013051597A1 (ja) 2011-10-04 2013-04-11 塩野義製薬株式会社 カテコール基を有するセフェム誘導体
US9021810B2 (en) 2012-01-27 2015-05-05 The University Of Kentucky Research Foundation Fossil-fuel-fired power plant
UY35103A (es) 2012-10-29 2014-05-30 Glaxo Group Ltd Compuestos de cefem 2-sustituidos
EP2912040A4 (en) 2012-10-29 2016-06-01 Shionogi & Co METHODS FOR PRODUCING INTERMEDIATES OF TYPE 2-ALKYLCEPHEM COMPOUNDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25965A (en) * 1988-06-06 1992-01-13 Fujisawa Pharmaceutical Co New cephem compounds which have antimicrobial activities

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI547496B (zh) * 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物

Also Published As

Publication number Publication date
JPH06510523A (ja) 1994-11-24
GB9111406D0 (en) 1991-07-17
WO1992021683A1 (en) 1992-12-10

Similar Documents

Publication Publication Date Title
TW202454B (en, 2012)
JPH10503501A (ja) 抗喘息、抗アレルギー、抗炎症及び免疫修飾作用を有するインドール、インダゾール、ピリドピロール及びピリドピラゾール誘導体
DE60016198T2 (de) Antibakterielle verbindungen
JP7409719B2 (ja) Erk阻害剤としてのチアゾロラクタム系化合物およびその使用
NZ192774A (en) 1-aryl-2-acylamino-3-fluoro-1-propanols;antibacterial compositions
JP2000515133A (ja) 血糖降下性および脂質低下性の化合物
WO1992000981A1 (en) Novel 3-substituted cephem compounds and processes for preparation thereof
KR20030090794A (ko) 세펨 화합물
EP1347759A1 (en) Antibacterial compounds
JPS63277660A (ja) 新規ヘテロ環式脂肪族カルボキシアミド誘導体及びその製法
WO2008003855A2 (fr) Utilisation de 2-benzoyl-imidazopyridines en thérapeutique
JP7299350B2 (ja) Rip-1キナーゼ阻害剤としての二環式化合物およびその使用
TW202453B (en, 2012)
CN103664996B (zh) 吲哚衍生物及其制备方法
JP4208464B2 (ja) ナフチリジン−3−カルボン酸誘導体の製造法
JP4208463B2 (ja) キノロンカルボン酸誘導体の製造に関する中間体
JP2007511597A (ja) 抗菌アミノキナゾリヂンヂオン誘導体
JPH0741484A (ja) セフェム化合物及び抗菌剤
AU615026B2 (en) Crystalline beta-lactam solvate
CN104804019B (zh) 一种具有抗菌能力的化合物及其制备方法与用途
JP6532459B2 (ja) 3−[(3−{[4−(4−モルホリニルメチル)−1h−ピロール−2−イル]メチレン}−2−オキソ−2,3−ジヒドロ−1h−インドール−5−イル)メチル]−1,3−チアゾリジン−2,4−ジオンの新規塩、その調製及びそれを含有する製剤
JPH0373548B2 (en, 2012)
JPS6322570A (ja) 1−メタンスルホニルオキシ−6−トリフルオロメチル−1h−ベンゾトリアゾ−ル及びセファロスポリン誘導体の製造方法
KR100264156B1 (ko) (e)-프로페닐4급암모늄세펨화합물및이의제조방법
JPH03118381A (ja) 新規化合物、その製法及びそれを含む医薬組成物